| 000 | 01689 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516182424.0 | ||
| 264 | 0 | _c20140630 | |
| 008 | 201406s 0 0 eng d | ||
| 022 | _a1932-6203 | ||
| 024 | 7 |
_a10.1371/journal.pone.0081004 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVandame, Delphine | |
| 245 | 0 | 0 |
_aDevelopment of NMDAR antagonists with reduced neurotoxic side effects: a study on GK11. _h[electronic resource] |
| 260 |
_bPloS one _c2013 |
||
| 300 |
_ae81004 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAstrocytes _xdrug effects |
| 650 | 0 | 4 |
_aCyclohexenes _xadverse effects |
| 650 | 0 | 4 |
_aDizocilpine Maleate _xadverse effects |
| 650 | 0 | 4 |
_aExcitatory Amino Acid Antagonists _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGyrus Cinguli _xdrug effects |
| 650 | 0 | 4 |
_aInflammation _xchemically induced |
| 650 | 0 | 4 | _aInjections, Intraperitoneal |
| 650 | 0 | 4 |
_aMemantine _xadverse effects |
| 650 | 0 | 4 |
_aMicroglia _xdrug effects |
| 650 | 0 | 4 |
_aNeurons _xdrug effects |
| 650 | 0 | 4 |
_aPiperidines _xadverse effects |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aReceptors, N-Methyl-D-Aspartate _xantagonists & inhibitors |
| 700 | 1 | _aUlmann, Lauriane | |
| 700 | 1 | _aTeigell, Marisa | |
| 700 | 1 | _aPrieto-Cappellini, Monica | |
| 700 | 1 | _aVignon, Jacques | |
| 700 | 1 | _aPrivat, Alain | |
| 700 | 1 | _aPerez-Polo, Regino | |
| 700 | 1 | _aNesic, Olivera | |
| 700 | 1 | _aHirbec, Helene | |
| 773 | 0 |
_tPloS one _gvol. 8 _gno. 11 _gp. e81004 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.pone.0081004 _zAvailable from publisher's website |
| 999 |
_c23292858 _d23292858 |
||